In the ever-evolving landscape of biotech startups, one name has recently emerged from stealth and captured the attention of both investors and pet lovers alike: Epiterna. Founded in 2022 by tduo Kevin Perez and Alejandro Ocampo, this Swiss-based company aims to revolutionize how we approach aging – not just for humans but also for our beloved furry companions.
The exciting news is that Prima Materia, the brainchild of Daniel Ek (yes, the mastermind behind Spotify) and Shakil Khan, has come onboard as a key investor, fueling Epiterna's vision with a significant investment of €10 million.
According to Alejandro Ocampo, the company's CEO, they have developed a unique high-throughput platform to evaluate drugs and their impact on healthy lifespan. Their ultimate goal is to help both pets and people live longer, healthier, and more fulfilling lives.
Ocampo sheds light on the essence of Epiterna's mission. Aging, he explains, is the primary risk factor for various diseases that affect humans and animals alike – think dementia, cancer, cardiovascular diseases, and more. But here's the intriguing part: the aging process is far from linear, and Epiterna firmly believes that it can be influenced. In fact, experiments have already shown promising results in slowing down aging and extending a healthy lifespan in laboratory animals.
What sets Epiterna apart is Ocampo's expertise and passion. With fifteen years of experience in scientific research focused on aging, he's no stranger to the intricacies of studying cellular and molecular processes to combat aging. This wealth of knowledge puts Epiterna in a prime position to turn these groundbreaking discoveries into practical solutions for a brighter and healthier future.
In a world where our pets are cherished members of the family, Epiterna's mission strikes a resonant chord. By translating their cutting-edge research into tangible solutions for companion dogs, cats, and humans, they are opening up a realm of possibilities where longer, healthier, and happier lives become more than just a distant dream.
This ambitious biotech startup is set on a future where age is no barrier to leading a fulfilling life. With a shared vision and a commitment to pushing the boundaries of scientific discovery, Epiterna stands poised to leave an indelible mark on the world of biotechnology and the lives of countless individuals and their beloved pets.
